The AXIN1 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population engineered for targeted disruption of the human AXIN1 gene. This loss-of-function model is ideal for probing Wnt/??-catenin signaling in a widely used epithelial cancer background. The polyclonal format provides a heterogeneous pool of edited cells suitable for robust functional studies without clonal isolation. Eliminating AXIN1 expression enables investigation of ??-catenin regulation and downstream transcriptional programs in a system compatible with high-throughput and mechanistic analyses.
HeLa cells are an immortalized cervical adenocarcinoma line with integrated HPV18, extensively used in cancer and cell biology research. Their robust growth and well-characterized molecular landscape make them a standard model for studying oncogenic pathways, including Wnt signaling. The epithelial origin and expression of key Wnt components facilitate the study of AXIN1 loss on ??-catenin stabilization and transcriptional activity.
AXIN1 is a scaffold protein within the ??-catenin destruction complex, interacting with APC, GSK-3??, CK1??, and ??-catenin. In the absence of Wnt ligands like Wnt3a, AXIN1 facilitates ??-catenin phosphorylation by GSK-3?? and CK1??, promoting its degradation. Wnt stimulation activates LRP5/6 and DVL, leading to complex disassembly and ??-catenin stabilization. AXIN1 also associates with PP2A and modulates JNK and TGF-?? signaling. Knockout of AXIN1 disrupts the destruction complex, causing constitutive ??-catenin accumulation and TCF/LEF-mediated transcription of targets such as MYC, CCND1, and AXIN2.
In HeLa cells, which exhibit low basal Wnt activity, AXIN1 loss leads to aberrant ??-catenin target gene activation, offering a powerful system to study Wnt-driven epithelial cancer phenotypes. This model is relevant to colorectal and hepatocellular carcinomas where AXIN1 mutations are common. It also enables exploration of crosstalk between Wnt signaling and HPV-associated oncogenesis. The polyclonal nature avoids clonal artifacts, capturing heterogeneous cellular responses.
Applications include functional dissection of Wnt/??-catenin signaling, ??-catenin localization studies, and drug screening for Wnt modulators. Typical assays: Western blot for AXIN1 and ??-catenin; RT-qPCR for MYC, CCND1, AXIN2; TOPFlash reporter; immunofluorescence; and proliferation, colony formation, and migration assays. High-throughput formats can identify inhibitors reversing ??-catenin-dependent phenotypes. For further information, please contact Ascent Research.
